Shandong Pharmaceutical Glass Co Ltd

SHG:600529 China Packaging & Containers
Market Cap
$1.77 Billion
CN¥13.01 Billion CNY
Market Cap Rank
#7311 Global
#1236 in China
Share Price
CN¥19.60
Change (1 day)
-0.10%
52-Week Range
CN¥19.50 - CN¥24.01
All Time High
CN¥73.95
Categories
Companies in China Packaging & Containers
About

Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more

Shandong Pharmaceutical Glass Co Ltd (600529) - Net Assets

Latest net assets as of December 2025: CN¥8.29 Billion CNY

Based on the latest financial reports, Shandong Pharmaceutical Glass Co Ltd (600529) has net assets worth CN¥8.29 Billion CNY as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥10.04 Billion) and total liabilities (CN¥1.75 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥8.29 Billion
% of Total Assets 82.58%
Annual Growth Rate 16.43%
5-Year Change 77.6%
10-Year Change 172.53%
Growth Volatility 35.9

Shandong Pharmaceutical Glass Co Ltd - Net Assets Trend (1999–2025)

This chart illustrates how Shandong Pharmaceutical Glass Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Shandong Pharmaceutical Glass Co Ltd (1999–2025)

The table below shows the annual net assets of Shandong Pharmaceutical Glass Co Ltd from 1999 to 2025.

Year Net Assets Change
2025-12-31 CN¥8.29 Billion +3.58%
2024-12-31 CN¥8.01 Billion +6.28%
2023-12-31 CN¥7.53 Billion +8.23%
2022-12-31 CN¥6.96 Billion +49.06%
2021-12-31 CN¥4.67 Billion +9.74%
2020-12-31 CN¥4.26 Billion +10.03%
2019-12-31 CN¥3.87 Billion +9.70%
2018-12-31 CN¥3.53 Billion +8.47%
2017-12-31 CN¥3.25 Billion +6.79%
2016-12-31 CN¥3.04 Billion +36.03%
2015-12-31 CN¥2.24 Billion +5.26%
2014-12-31 CN¥2.13 Billion +4.71%
2013-12-31 CN¥2.03 Billion +4.62%
2012-12-31 CN¥1.94 Billion +4.90%
2011-12-31 CN¥1.85 Billion +5.98%
2010-12-31 CN¥1.75 Billion +9.55%
2009-12-31 CN¥1.59 Billion +9.68%
2008-12-31 CN¥1.45 Billion +11.16%
2007-12-31 CN¥1.31 Billion +41.31%
2006-12-31 CN¥924.74 Million +7.33%
2005-12-31 CN¥861.57 Million +8.08%
2004-12-31 CN¥797.19 Million +9.92%
2003-12-31 CN¥725.23 Million +11.52%
2002-12-31 CN¥650.32 Million +189.88%
2001-12-31 CN¥224.34 Million +19.12%
2000-12-31 CN¥188.33 Million +18.61%
1999-12-31 CN¥158.78 Million --

Equity Component Analysis

This analysis shows how different components contribute to Shandong Pharmaceutical Glass Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 7534.9% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CN¥4.20 Billion 50.67%
Other Components CN¥4.09 Billion 49.33%
Total Equity CN¥8.29 Billion 100.00%

Shandong Pharmaceutical Glass Co Ltd Competitors by Market Cap

The table below lists competitors of Shandong Pharmaceutical Glass Co Ltd ranked by their market capitalization.

Company Market Cap
Partner Communications Company Ltd.
PINK:PTNRF
 		$1.01 Billion
Grupo Gigante S. A. B. de C. V
PINK:GPGNF
 		$1.01 Billion
Redde Northgate PLC
F:21W
 		$1.01 Billion
Sixt SE
PINK:SIXGF
 		$1.01 Billion
Universal Robina Corporation
PINK:UVRBF
 		$1.01 Billion
GLORY LTD
F:3O5
 		$1.01 Billion
Vizio Holding Corp
NYSE:VZIO
 		$1.01 Billion
Guanglian Aviation Industry Co Ltd
SHE:300900
 		$1.01 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shandong Pharmaceutical Glass Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 8,007,769,690 to 8,294,642,156, a change of 286,872,466 (3.6%).
  • Net income of 689,626,041 contributed positively to equity growth.
  • Dividend payments of 370,341,793 reduced retained earnings.
  • Other comprehensive income decreased equity by 722,947,812.
  • Other factors increased equity by 690,536,031.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥689.63 Million +8.31%
Dividends Paid CN¥370.34 Million -4.46%
Other Comprehensive Income CN¥-722.95 Million -8.72%
Other Changes CN¥690.54 Million +8.33%
Total Change CN¥- 3.58%

Book Value vs Market Value Analysis

This analysis compares Shandong Pharmaceutical Glass Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.57x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 56.12x to 1.57x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-12-31 CN¥0.35 CN¥19.60 x
2000-12-31 CN¥0.42 CN¥19.60 x
2001-12-31 CN¥0.49 CN¥19.60 x
2002-12-31 CN¥1.46 CN¥19.60 x
2003-12-31 CN¥1.63 CN¥19.60 x
2004-12-31 CN¥1.80 CN¥19.60 x
2005-12-31 CN¥1.94 CN¥19.60 x
2006-12-31 CN¥2.11 CN¥19.60 x
2007-12-31 CN¥2.67 CN¥19.60 x
2008-12-31 CN¥2.90 CN¥19.60 x
2009-12-31 CN¥3.15 CN¥19.60 x
2010-12-31 CN¥3.47 CN¥19.60 x
2011-12-31 CN¥3.63 CN¥19.60 x
2012-12-31 CN¥3.88 CN¥19.60 x
2013-12-31 CN¥4.06 CN¥19.60 x
2014-12-31 CN¥4.16 CN¥19.60 x
2015-12-31 CN¥4.38 CN¥19.60 x
2016-12-31 CN¥6.06 CN¥19.60 x
2017-12-31 CN¥5.48 CN¥19.60 x
2018-12-31 CN¥5.91 CN¥19.60 x
2019-12-31 CN¥6.50 CN¥19.60 x
2020-12-31 CN¥7.15 CN¥19.60 x
2021-12-31 CN¥7.85 CN¥19.60 x
2022-12-31 CN¥11.60 CN¥19.60 x
2023-12-31 CN¥11.36 CN¥19.60 x
2024-12-31 CN¥12.06 CN¥19.60 x
2025-12-31 CN¥12.50 CN¥19.60 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shandong Pharmaceutical Glass Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 8.31%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 15.41%
  • • Asset Turnover: 0.45x
  • • Equity Multiplier: 1.21x
  • Recent ROE (8.31%) is below the historical average (10.04%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 18.41% 12.18% 0.65x 2.31x CN¥12.86 Million
2000 16.75% 10.39% 0.74x 2.17x CN¥12.27 Million
2001 17.34% 10.67% 0.75x 2.17x CN¥15.82 Million
2002 8.53% 12.96% 0.45x 1.47x CN¥-9.40 Million
2003 9.80% 15.00% 0.45x 1.45x CN¥-1.40 Million
2004 9.62% 13.51% 0.45x 1.57x CN¥-2.99 Million
2005 9.70% 12.27% 0.47x 1.68x CN¥-2.57 Million
2006 10.41% 11.62% 0.51x 1.77x CN¥3.74 Million
2007 8.51% 11.20% 0.53x 1.43x CN¥-19.50 Million
2008 9.79% 12.26% 0.58x 1.37x CN¥-3.10 Million
2009 9.08% 11.62% 0.56x 1.39x CN¥-14.66 Million
2010 9.84% 11.32% 0.60x 1.45x CN¥-2.84 Million
2011 7.16% 9.49% 0.56x 1.35x CN¥-52.44 Million
2012 6.18% 8.16% 0.56x 1.35x CN¥-74.21 Million
2013 6.03% 7.92% 0.57x 1.33x CN¥-80.66 Million
2014 5.89% 7.37% 0.60x 1.33x CN¥-86.93 Million
2015 6.52% 8.44% 0.58x 1.33x CN¥-77.48 Million
2016 6.23% 9.22% 0.53x 1.28x CN¥-114.76 Million
2017 8.08% 11.27% 0.56x 1.29x CN¥-62.27 Million
2018 10.16% 13.86% 0.56x 1.31x CN¥5.64 Million
2019 11.86% 15.33% 0.58x 1.34x CN¥71.91 Million
2020 13.26% 16.47% 0.61x 1.32x CN¥138.85 Million
2021 12.66% 15.25% 0.60x 1.37x CN¥124.06 Million
2022 8.88% 14.77% 0.48x 1.26x CN¥-77.88 Million
2023 10.30% 15.57% 0.53x 1.24x CN¥22.35 Million
2024 11.78% 18.40% 0.51x 1.27x CN¥142.21 Million
2025 8.31% 15.41% 0.45x 1.21x CN¥-139.84 Million

Industry Comparison

This section compares Shandong Pharmaceutical Glass Co Ltd's net assets metrics with peer companies in the Packaging & Containers industry.

Industry Context

  • Industry: Packaging & Containers
  • Average net assets among peers: $2,787,109,642
  • Average return on equity (ROE) among peers: 9.03%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Shandong Pharmaceutical Glass Co Ltd (600529) CN¥8.29 Billion 18.41% 0.21x $1.01 Billion
Zhuhai Zhongfu Enterprise Co Ltd (000659) $235.46 Million 0.00% 1.21x $570.17 Million
Huangshan Novel Co Ltd (002014) $1.80 Billion 11.44% 0.34x $322.24 Million
Shenzhen Jinjia Color Printing Group Co Ltd (002191) $7.23 Billion 12.12% 0.20x $500.47 Million
Xiamen Hexing Packaging Printing Co Ltd (002228) $3.79 Billion 7.65% 1.15x $306.80 Million
Shenzhen Beauty Star Co Ltd (002243) $145.05 Million 30.37% 2.00x $735.89 Million
Zhejiang Great Southeast Co Ltd (002263) $1.70 Billion 4.57% 0.55x $656.36 Million
Shenzhen MYS Environmental Protection & Technology Co Ltd (002303) $5.25 Billion 10.20% 0.39x $463.91 Million
Shandong Lipeng Co Ltd (002374) $3.15 Billion 4.95% 0.68x $415.24 Million
Zhejiang Zhongcheng Packing Material Co Ltd (002522) $2.31 Billion 4.51% 0.59x $535.92 Million
Shanghai Luxin Packing Materials Science&Technology Co Ltd (002565) $2.28 Billion 4.45% 0.59x $1.10 Billion